Please login to the form below

Not currently logged in
Email:
Password:

R&D news in brief

Our weekly round-up of the R&D news in brief

PowderMed files for H5N1 trial
British firm, PowderMed is hoping to run the first human clinical tests of a needle-free vaccine against the H5N1 (avian flu) virus, after filing for regulatory permission in the UK.

The new vaccine, based on PowderMed's proprietary technology, fires gold particles coated with DNA (encoding genes specific to the flu strain) at supersonic speed into the immune cells of the skin.

A previous PowderMed study in the US found that the technology was able to produce 100 per cent protective immune responses in adult volunteers against normal seasonal flu.

FDA to explore adaptive clinical trials
The US Food and Drug Administration (FDA) has announced plans to develop regulatory guidelines for o-called `adaptive' clinical trials - tests which change course as they go along.

The results of an adaptive trial are observed closely, and modifications are made to the design as it progresses, usually based on findings such as the efficacy of treatments or which group of patients appears to be benefiting most from a particular trial.

ìWe think it's time to start exploring the appropriate use of these designs in the appropriate situations,î said Robert O'Neill, director of the FDA's office of biostatistics.

30th September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Genetic Digital

Genetic Digital specialises in developing digital marketing solutions for the healthcare, medical and pharmaceutical sectors. From developing a digital strategy,...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...